A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent

Blood

Volumn 89, Issue 9, 1997, Pages 3219-3227

  Kelley, Robert F ^a   Refino, Canio J ^a   O'Connell, Mark P ^a   Modi, Nishit ^a   Sehl, Pat ^a   Lowe, David ^a   Pater, Cheryl ^a   Bunting, Stuart ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN;

AMINO ACID SUBSTITUTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTICOAGULATION; ARTICLE; BLEEDING TIME; BLOOD CLOT LYSIS; DRUG POTENCY; HEMOSTASIS; HUMAN; HUMAN CELL; MEMBRANE BINDING; MUTANT; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

EID: 0030917536     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3219     Document Type: Article

References (40)

1. Davie EW, Fujikawa K, Kisiel W: The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 30:10363, 1991
2. Ruf W, Edgington TS: Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 8:385, 1994
3. Nemerson Y, Repke D: Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor. Thromb Res 40:351, 1985
4. Bom VJJ, Bertina RM: The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor Vu. Biochem J 265:327, 1990
5. Morrissey JH, Fakhrai H, Edgington TS: Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation cascade. Cell 50:129, 1987
6. Scarpati EM, Wen D, Graze GJ, Miletich JP, Flandermeyer RR, Siegel MR, Sadler JE: Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 26:5324, 1987
7. Spicer EK, Horton R, Bloem L, Bach R, Williams KR, Guha A, Kraus J, Lin TC, Nemerson Y, Konigsberg WH: Isolation of cDNA clones coding for human tissue factor: Primary structure of the protein and cDNA. Proc Natl Acad Sei USA 84:5148, 1987
8. Wilcox JN, Smith KM, Schwanz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sei USA 86:2839, 1989
9. Gregory SA, Morrissey JH, Edgington TS: Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 9:2752, 1989
10. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS: Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 33:127, 1991
11. Pawashe AB, Golino P, Ambrosio G, Miglliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg WH, Ezekowitz MD: A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 74:56, 1994
12. Riechmann L, Clark M, Waldmann H, Winter G: Reshaping human antibodies for therapy. Nature 332:323, 1988
13. Roy S, Hass PE, Bourell JH, Henzel WJ, Vehar GA: Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. J Biol Chem 266:22063, 1991
14. Ruf W, Miles DJ, Rehemtulla A, Edgington TS: Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor Vila protease complex. J Biol Chem 267:6375, 1992
15. Banner DW, D'Arcy A, Chéne C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D: The crystal structure of the complex of blood coagulation factor Vila with soluble tissue factor. Nature 380:41, 1996
16. Fiore MM, Neuenschwander PF, Morrissey JH: The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor Vila. J Biol Chem 269:143, 1994
17. Neuenschwander PF, Morrissey JH: Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. J Biol Chem 267:14477, 1992
18. Paborsky LR, Caras IW, Fisher KL, Gorman CM: Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J Biol Chem 266:21911, 1991
19. Paborsky LR, Täte KM, Harris RJ, Yansura DG, Band L, McCray G, Gorman CM, O'Brien DP, Chang JY, Swartz JR, Fung VP, Thomas JN, Vehar GA: Purification of recombinant human tissue factor. Biochemistry 28:8072, 1989
20. Mimms LT, Zampighi G, Nozaki Y, Tanford C, Reynolds J: Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry 20:833, 1981
21. Bach R, Gentry R, Nemerson Y: Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry 25:4007, 1986
22. Kelley RF, Costas KE, O'Connell MP, Lazarus RA: Analysis of the factor Vila binding site on human tissue factor: Effects of tissue factor mutations on the kinetics and thermodynamics of binding. Biochemistry 34:10383, 1995
23. Bourell JH, Clauser KP, Kelley R, Carter P, Stults JT: Electrospray ionization mass spectrometry of recombinantly engineered antibody fragments. Anal Chem 66:2088, 1994
24. Warren HS, Glennon ML, Wainwright N, Amato SF, Black KM, Kirsch SJ, Riveau OR, Whyte RI, Zapol WM, Novitsky TJ: Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor. Infec Immun 60:2506, 1992
25. Andrews BS, Rehemtulla A, Fowler BJ, Edgington TS, Mackman N: Conservation of tissue factor primary sequence among three mammalian species. Gene 98:265, 1991
26. Dennis MS, Lazarus RA: Kunitz domain inhibitors of tissue factor-factor Vila. I. Potent inhibitors selected from libraries by phage display. J Biol Chem 269:22129, 1994
27. Paborsky LR, Fendly BM, Fisher KL, Lawn RM, Marks BJ, McCray G, Tate KM, Vehar GA, German CM: Mammalian cell transient expression of tissue factor for the production of antigen. Protein Eng 3:547, 1990
28. Karlsson R, Roos H, Fägerstam L, Persson B: Kinetic and concentration analysis using BIA technology. Methods: A companion to Methods in Enzymology 6:99, 1994
29. Kelley RF: Thermodynamics of protein-protein interaction studied by using BIAcore and single-site mutagenesis. Methods: A Companion to Methods in Enzymology 6:111, 1994
30. Furie B, Furie BC: The molecular basis of blood coagulation. Cell 53:505, 1988
31. Segal IH: Enzyme kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems. New York, NY, Wiley, 1975, p 227
32. Waxman E, Ross JBA, Laue TM, Guha A, Thiruvikraman SV, Lin TC, Konigsberg WH, Nemerson Y: Tissue factor and its extracellular soluble domain: The relationship between intermolecular association with factor Vila and enzymatic activity of the complex. Biochemistry 31:3998, 1992
33. Ruf W, Schullek JR, Stone MJ, Edgington TS: Mutational mapping of functional residues in tissue factor: Identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry 33:1565, 1994
34. Gibbs CS, McCurdy SN, Leung LLK, Paborsky LR: Identification of the factor Vila binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis. Biochemistry 33:14003, 1994
35. Gibaldi M, Perrier D: Pharmacokinetics (ed 2). New York, NY, Dekker, 1982
36. Muller YA, Ultsch MH, Kelley RF, deVos AM: Structure of the extracellular domain of human tissue factor: Location the factor Vila binding site. Biochemistry 33:10864, 1994
37. Harlos K, Martin DMA, O'Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EGD, Boys CWG: Crystal structure of the extracellular region of human tissue factor. Nature 370:662, 1994
38. Huang Q, Neuenschwander PF, Resaie AR, Morrissey JH: Substrate recognition by tissue factor-factor Vila. Evidence for the interaction of residues K165 and K166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J Biol Chem 271:21752, 1996
39. Janson TL, Stormorken H, Prydz H: Species specificity of tissue thromboplastin. Haemostasis 14:440, 1984
40. Ruf W, Miles DJ, Rehemtulla A, Edgington TS: Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII. J Biol Chem 267:22206, 1992